Official ESCRS | European Society of Cataract & Refractive Surgeons
Vienna 2018 Delegate Registration Programme Exhibition Virtual Exhibition Satellites 2018 Survey


escrs app advert

Descemet's membrane endothelial keratoplasty for treatment of iridocorneal endothelial syndrome

Search Title by author or title

Session Details

Session Title: Presented Poster Session: Cornea: Surgical

Venue: Poster Village: Pod 3

First Author: : M.Ziaei NEW ZEALAND

Co Author(s): :    A. Gokul   D. Patel   C. McGhee                 

Abstract Details


To describe the use of Descemet membrane endothelial keratoplasty (DMEK) to treat corneal edema associated with iridocorneal endothelial (ICE) syndrome


University hospital tertiary referral center.


In this retrospective, consecutive, interventional case series, the corneal endothelium was selectively replaced by the DMEK technique in eyes with ICE syndrome. Three eyes were treated at one center between March 2016 and May 2017.


DMEK successfully resolved corneal edema in 2 female and 1 male patient with unilateral ICE syndrome aged between 36 to 63 years. Follow-up ranged from 6 to 20 months (mean: 12.6 months). Best spectacle-corrected visual acuity at the final visit was -0.10 to 0.30 logMAR, with a mean spherical equivalent of 0.33 ± 0.51 diopters (D). The mean endothelial cell count at final followup was 35.1 ± 3.99%.


DMEK is a safe and successful procedure to treat corneal edema and associated visual loss and pain caused by ICE syndrome. Visual recovery is rapid and graft failure and cell loss appear to be comparable to uncomplicated cases.

Financial Disclosure:


Back to previous